Editas Medicine
Editas Medicine33About
What does Editas Medicine do?
Editas Medicine harnesses the power of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases. Their goal is to discover, develop, manufacture, and commercialize transformative, durable genomic medicines for many diseases. They are motivated to deliver these transformative medicines to the greatest number of patients around the world.
What is Editas Medicine's revenue?
StartupHub estimates Editas Medicine's annual revenue at $35.0M (range $20.3M to $57.0M, 64% confidence), based on comparable companies in the sector.
What is Editas Medicine's valuation?
StartupHub estimates Editas Medicine's effective valuation at $722.5M (range $525.0M to $1.3B, 10% confidence), based on comparable companies in the sector.
How much funding has Editas Medicine raised?
Editas Medicine has raised a total of $210M in funding. The most recent round on record is Series B.
Where is Editas Medicine headquartered?
Editas Medicine is headquartered in Cambridge, United States.
When was Editas Medicine founded?
Editas Medicine was founded in 2013.
What industry does Editas Medicine operate in?
Editas Medicine operates in Biotech, MedTech, Genomics, Drug Discovery, Clinical Trials, CRISPR.
How many employees does Editas Medicine have?
Editas Medicine has approximately 185 people on record.
No comments yet. Be the first to share your take.